Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction
- 30 June 2006
- journal article
- Published by Elsevier in Clinical Biochemistry
- Vol. 39 (6) , 640-645
- https://doi.org/10.1016/j.clinbiochem.2006.01.021
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- B-Type Natriuretic Peptide as a Biomarker Beyond Heart Failure: Speculations and OpportunitiesMayo Clinic Proceedings, 2005
- Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathyJournal of the American College of Cardiology, 2004
- Analytical correlation between plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in patients presenting with dyspneaClinical Biochemistry, 2004
- NT‐proBNP in heart failure: therapy decisions and monitoringEuropean Journal of Heart Failure, 2004
- Biochemical diagnosis of impaired left ventricular ejection fraction - comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP)cclm, 2004
- Multicenter analytical performance evaluation of the Elecsys® proBNP assaycclm, 2004
- B-type natriuretic peptide in cardiovascular diseaseThe Lancet, 2003
- A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot studyJournal of the American College of Cardiology, 2001
- Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrationsThe Lancet, 2000
- Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.Circulation, 1994